Cancer Research Technology and Pangaea Biotech sign license agreement to develop new cancer drugs

by Pangaea Biotech

CANCER Research Technology (CRT), the development and commercialisation arm of Cancer Research UK – has entered into a license agreement with Pangaea Biotech to develop p21-activated kinase (PAK) in...

Read more

DiaCarta and Pangaea Biotech Join Forces to Launch Non-Invasive Tests to Detect Genetic Mutations in Blood from Cancer Patients

by Pangaea Biotech

This agreement gives Pangaea access to the experience of DiaCarta, a leader in development and commercialization of personalized diagnostic tools, while DiaCarta stands to benefit from that of an inte...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

A dietary supplement has beneficial effe...

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...

Photos Stream